Minerva Neurosciences Inc
NERV
NASDAQ
Biotechnology
$4.58
USD
+0.66 (+16.84%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $187.17M
Volume 340.0K
Price Target
$10.00 – $10.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $10.00 and a min estimate of $10.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$10.00
-$0.5 vs prior
Implied Upside
+118.3%
-10.9% vs prior
Analyst Covering
1
-1 vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
33%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Biren Amin | Piper Sandler | Buy | Upgraded | 1 day ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
PEPG
PepGen Inc
$2.99
▲ +0.3%
ALEC
Alector Inc
$1.96
▼ -3.9%
WHWK
Whitehawk Therapeutics Inc
$4.46
▼ -4.7%
NBP
NovaBridge Biosciences
$1.96
▲ +3.2%
IVVD
Invivyd Inc
$0.7200
▲ +5.1%
TNXP
Tonix Pharmaceuticals Holding Corp
$12.71
▲ +1.7%
DTIL
Precision BioSciences Inc
$7.43
▲ +1.8%
RNA
Atrium Therapeutics Inc
$12.84
▲ +4.1%
IMUX
Immunic Inc
$16.06
▼ -3.1%